| Literature DB >> 27571343 |
Douglas Huber1, Carolyn Curtis2, Laili Irani3, Sara Pappa4, Lauren Arrington5.
Abstract
Worldwide 75 million women need postabortion care (PAC) services each year following safe or unsafe induced abortions and miscarriages. We reviewed more than 550 studies on PAC published between 1994 and 2013 in the peer-reviewed and gray literature, covering emergency treatment, postabortion family planning, organization of services, and related topics that impact practices and health outcomes, particularly in the Global South. In this article, we present findings from studies with strong evidence that have major implications for programs and practice. For example, vacuum aspiration reduced morbidity, costs, and time in comparison to sharp curettage. Misoprostol 400 mcg sublingually or 600 mcg orally achieved 89% to 99% complete evacuation rates within 2 weeks in multiple studies and was comparable in effectiveness, safety, and acceptability to manual vacuum aspiration. Misoprostol was safely introduced in several PAC programs through mid-level providers, extending services to secondary hospitals and primary health centers. In multiple studies, postabortion family planning uptake before discharge increased by 30-70 percentage points within 1-3 years of strengthening postabortion family planning services; in some cases, increases up to 60 percentage points in 4 months were achieved. Immediate postabortion contraceptive acceptance increased on average from 32% before the interventions to 69% post-intervention. Several studies found that women receiving immediate postabortion intrauterine devices and implants had fewer unintended pregnancies and repeat abortions than those who were offered delayed insertions. Postabortion family planning is endorsed by the professional organizations of obstetricians/gynecologists, midwives, and nurses as a standard of practice; major donors agree, and governments should be encouraged to provide universal access to postabortion family planning. Important program recommendations include offering all postabortion women family planning counseling and services before leaving the facility, especially because fertility returns rapidly (within 2 to 3 weeks); postabortion family planning services can be quickly replicated to multiple sites with high acceptance rates. Voluntary family planning uptake by method should always be monitored to document program and provider performance. In addition, vacuum aspiration and misoprostol should replace sharp curettage to treat incomplete abortion for women who meet eligibility criteria. © Huber et al.Entities:
Mesh:
Year: 2016 PMID: 27571343 PMCID: PMC5042702 DOI: 10.9745/GHSP-D-16-00052
Source DB: PubMed Journal: Glob Health Sci Pract ISSN: 2169-575X
Gray Scale of Strength of Evidence
| Strength of Evidence | Description |
|---|---|
| I | Strong evidence from at least one systematic review of multiple well-designed, randomized controlled trials. |
| II | Strong evidence from at least one properly designed, randomized controlled trial of appropriate size. |
| IIIa | Evidence from well-designed trials/studies without randomization that include a control group (e.g., quasi-experimental, matched case-control studies, pre-post with control group). |
| IIIb | Evidence from well-designed trials/studies without randomization that do not include a control group (e.g., single group pre-post, cohort, time series/interrupted time series). |
| IV | Evidence from well-designed, nonexperimental studies from more than one center or research group. |
| V | Opinions of respected authorities, based on clinical evidence, descriptive studies, or reports of expert committees. |
Note: Gray includes 5 levels of evidence. For the “What Works” compendiums, level III was subdivided to differentiate between studies and evaluations whose design included control groups (IIIa) and those that did not (IIIb). Qualitative studies can be classified as either level IV or V, depending on number of study participants and other factors. For more detail about these types of studies and their strengths and weaknesses, see Gray (2009).
Effectiveness and Satisfaction With Treatment for Incomplete Abortion, Misoprostol Compared With Surgical Evacuation, 10 Countries, 2005–2012
| Article | Country (Sample Size) | Study Design: Misoprostol/ Surgical Comparison Group | Effectiveness: % With Complete Evacuation | % Client Satisfaction With Procedure | Comments |
|---|---|---|---|---|---|
| Blandine 2012 | Burkina Faso (N = 99) | 400 mcg misoprostol sublingually/ referral for surgical | M: 98% | M: 99% | PAC with misoprostol introduced to 2 district hospitals with no previous PAC service. All eligible women chose misoprostol over optional referral for MVA. |
| Dao 2007 | Burkina Faso (N = 447) | 600 mcg misoprostol orally/MVA | M: 94% | M: 97% | 2 teaching hospitals. |
| Weeks 2005 | Uganda (N = 317) | 600 mcg misoprostol orally/MVA | M: 96% | M: 94% | Misoprostol was associated with less pain and fewer complications but increased bleeding. All received antibiotics after treatment. |
| Taylor 2011 | Ghana (N = 230) | 600 mcg misoprostol orally/MVA | M: 98% | M: 94% | 44% were very satisfied with misoprostol vs. 8% with MVA; 95% of those treated with misoprostol would choose it again vs. 36% treated with MVA. |
| Shwekerela 2007 | Tanzania (N = 150) | 600 mcg misoprostol orally/MVA | M: 99% | M: 99% | 75% were very satisfied with misoprostol vs.55% with MVA; more side effects were associated with misoprostol; greater pain with MVA. |
| Bique 2007 | Mozambique (N = 270) | 600 mcg misoprostol orally/MVA | M: 91% | M: 96% | 87% were very satisfied with misoprostol vs. 37% with MVA; trained midwife provided MVA with only verbal anesthesia; tertiary hospital site. |
| Montesinos 2011 | Ecuador (N = 242) | 600 mcg misoprostol orally/MVA | M: 94% | M: 96% | 47% were very satisfied with misoprostol vs. 40% with MVA; ultrasound use decreased threefold for misoprostol and MVA in 1 year. |
| Shochet 2012 | Senegal (N = 199) | 400 mcg misoprostol sublingually/ standard surgical care (MVA or D&C) | Antibiotics given with the surgical option; success rates much higher with misoprostol after first month from introduction. Ultrasound not needed on site. Nurses and midwives had prominent roles in care in Burkina Faso, Niger, and Senegal. |
Abbreviations: D&C, dilation and curettage; M, misoprostol; MVA, manual vacuum aspiration; PAC, postabortion care; S, surgical.